A recently accepted notion of RCC progression is that VHL mutation function as an initial event to drive tumorigenesis, while PBRM1, BAP1 and SETD2 subsequent trigger defects in DNA repair system and abnormal tumor growth (50). Here, SETD2 is linked to renal cell carcinoma.